First Time Loading...

SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 59 600 KRW 1.36%
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
SK Bioscience Co Ltd

Wall Street analysts forecast SK Bioscience Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SK Bioscience Co Ltd is 56 537.14 KRW with a low forecast of 35 350 KRW and a high forecast of 75 600 KRW.

Lowest Forecast
Wall Street Target
35 350 KRW
41% Downside
Average Forecast
Wall Street Target
56 537.14 KRW
5% Downside
Highest Forecast
Wall Street Target
75 600 KRW
27% Upside
Lowest
Price Target
35 350 KRW
41% Downside
Average
Price Target
56 537.14 KRW
5% Downside
Highest
Price Target
75 600 KRW
27% Upside
SK Bioscience Co Ltd Competitors:
Price Targets
AGIO
Agios Pharmaceuticals Inc
33% Upside
IPSC
Century Therapeutics Inc
349% Upside
ORGO
Organogenesis Holdings Inc
102% Upside
Y
301301
Yili Chuanning Biotechnology Co Ltd
37% Downside
AGIO
Agios Pharmaceuticals Inc
33% Upside
IPSC
Century Therapeutics Inc
349% Upside
ORGO
Organogenesis Holdings Inc
102% Upside
Y
301301
Yili Chuanning Biotechnology Co Ltd
37% Downside
INBX
Inhibrx Inc
5% Upside
OVID
Ovid Therapeutics Inc
164% Upside
6160
Beigene Ltd
39% Upside
ANIK
Anika Therapeutics Inc
9% Upside

Revenue
Forecast

Revenue Estimate
SK Bioscience Co Ltd

For the last 4 years the compound annual growth rate for SK Bioscience Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is -1%.

19%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
SK Bioscience Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
SK Bioscience Co Ltd

For the last 4 years the compound annual growth rate for SK Bioscience Co Ltd's net income is 11%.

11%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SK Bioscience Co Ltd's stock price target?
Price Target
56 537.14 KRW

According to Wall Street analysts, the average 1-year price target for SK Bioscience Co Ltd is 56 537.14 KRW with a low forecast of 35 350 KRW and a high forecast of 75 600 KRW.

What is SK Bioscience Co Ltd's Revenue forecast?
Projected CAGR
-1%

For the last 4 years the compound annual growth rate for SK Bioscience Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is -1%.

ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.